Back
Can Fite Biofarma Stock Price Chart
Sponsored
CANF
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
42
CANF
Can Fite Biofarma
Last Price:
2.00
Seasonality Move:
-4.74%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CANF is experiencing slight buying pressure.
Can Fite Biofarma Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.03 | Sell |
20-day SMA: | 2.17 | Sell |
50-day SMA: | 2.23 | Sell |
200-day SMA: | 2.4 | Sell |
8-day EMA: | 2.04 | Sell |
20-day EMA: | 2.14 | Sell |
50-day EMA: | 2.26 | Sell |
200-day EMA: | 2.46 | Sell |
Can Fite Biofarma Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 38.17 | Sell |
Chaikin Money Flow: | 15081 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2 - 2.58) | Sell |
Bollinger Bands (100): | (1.99 - 3.07) | Sell |
Can Fite Biofarma Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Can Fite Biofarma Stock
Is Can Fite Biofarma Stock a Buy?
- Can Fite Biofarma share price is 2.01 while CANF 8-day simple moving average is 2.03, which is a Sell signal.
- The stock price of CANF is 2.01 while Can Fite Biofarma 20-day SMA is 2.17, which makes it a Sell.
- Can Fite Biofarma 50-day simple moving average is 2.23 while CANF share price is 2.01, making it a Sell technically.
- CANF stock price is 2.01 and Can Fite Biofarma 200-day simple moving average is 2.40, creating a Sell signal.
CANF Technical Analysis vs Fundamental Analysis
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Is Can Fite Biofarma a Buy or a Sell?
-
Can Fite Biofarma stock is rated a Sell
The current Can Fite Biofarma [CANF] share price is $2.01. The Score for CANF is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
Can Fite Biofarma Stock Info
Market Cap:
12.25M
Price in USD:
2.01
Share Volume:
95.51K
Can Fite Biofarma 52-Week Range
52-Week High:
4.69
52-Week Low:
1.83
Sell
42
Can Fite Biofarma (CANF)
is a Sell
Can Fite Biofarma Share Price Forecast
-
What is the Can Fite Biofarma stock price today?
The Can Fite Biofarma stock price is 2.01 USD today. -
Will CANF stock go up or go down?
Can Fite Biofarma> share price is forecast to RISE/FALL based on technical indicators -
Is Can Fite Biofarma overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Can Fite Biofarma is overvalued.
Is Can Fite Biofarma Stock a Buy?
- Can Fite Biofarma share price is 2.01 while CANF 8-day exponential moving average is 2.04, which is a Sell signal.
- The stock price of CANF is 2.01 while Can Fite Biofarma 20-day EMA is 2.14, which makes it a Sell.
- Can Fite Biofarma 50-day exponential moving average is 2.26 while CANF share price is 2.01, making it a Sell technically.
- CANF stock price is 2.01 and Can Fite Biofarma 200-day simple moving average is 2.46, creating a Sell signal.
Fundamental Analysis of Can Fite Biofarma
Is Can Fite Biofarma a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and a decrease next year of $0.10 per share.
Technical Analysis of Can Fite Biofarma
Should I short Can Fite Biofarma stock?
- CANF Moving Average Covergence Divergence (MACD) indicator is -0.1, suggesting Can Fite Biofarma is a Sell
- Can Fite Biofarma Relative Strength Index (RSI) is 38.17, which suggest Can Fite Biofarma is oversold
- The Bollinger Bands (25) for Can Fite Biofarma is (2 - 2.58), which suggest Can Fite Biofarma is a Sell
- The Bollinger Bands (100) for Can Fite Biofarma is (1.99 - 3.07), which suggest Can Fite Biofarma is a Sell
* Can Fite Biofarma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.